Alirocumab Has Greater Reduction of LDL-C Than Ezetimibe in Patients with Statin Intolerance

Article Information

DOI 
http://dx.doi.org/10.1177/155989771452008
Published By 
SAGE Publications
Print ISSN 
1559-8977
Online ISSN 
2155-756X
Copyright & Usage 
© 2014 MD Conference Express®

Author Information

  1. Emma Hitt Nichols, PhD
  1. Patrick M. Moriarty, MD
    1. University of Kansas Medical Center, Kansas City, Kansas, USA
View Full Text

Article usage

AbstractFullPDF
Apr 20151000
May 2015800
Jun 2015300
Jul 2015111
Aug 2015100
Sep 2015300
Oct 2015233
Nov 2015100
Total2944

Note: Article usage statistics are calculated and reported monthly.

Cited By...

  • No citing articles found.
Back to top

Tools

View Full Page PDF
Citation Tools
Email
Alirocumab Has Greater Reduction of LDL-C Than Ezetimibe in Patients with Statin Intolerance
Permalink: Copy
Linkedin Share Button del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo StumbleUpon logo

Table of contents

Cited By...

  • No citing articles found.

Keywords

ODYSSEY
Lipid Disorders
Cardiology Clinical Trials